evidence: This recommendation, which applies to patients with COVID-19 of any disease severity, is now part of WHO’s guidelines on COVID-19 treatments. [...] Previous recommendations on the use of therapeutics for COVID-19: [...] - Strong recommendation against the use of hydroxychloroquine or chloroquine for treatment of COVID-19 of any severity - Strong recommendation against administering lopinavir/ritonavir for treatment of COVID-19 of any severity - Conditional recommendation for the use of low dose anticoagulants in hospitalized patients (this recommendation is part of the clinical management guidelines). We suggest the use of low dose anticoagulants rather than higher doses, unless otherwise indicated.